查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768797

全球自動輸血系統市場

Autotransfusion Systems
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 144 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計到 2030 年全球自動輸血系統市場規模將達到 4.677 億美元

全球自動輸血系統市場規模預計在2024年為3.665億美元，到2030年將達到4.677億美元，在2024-2030年的分析期間內，複合年成長率為4.1%。自體輸血產品是本報告分析的細分市場之一，預計其複合年成長率為4.5%，到分析期結束時達到3.362億美元。自動輸血配件細分市場的複合年成長率預計在分析期間為3.3%。

美國市場規模估計為 1.002 億美元，中國市場預計複合年成長率為 4.0%

美國自動輸血系統市場規模預計2024年達到1.002億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到7,470萬美元，在2024-2030年的分析期間內，複合年成長率為4.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間的複合年成長率分別為3.9%和3.5%。在歐洲，預計德國的複合年成長率為4.2%。

全球自動輸血系統市場－主要趨勢與促進因素摘要

什麼是自動輸血系統？它如何改變手術中的血液管理？

自體輸血系統是用於在手術中收集、過濾和回輸患者自身血液的醫療設備，它改變了手術室和創傷環境中的血液管理方式。傳統上，手術中需要血液的患者依賴捐贈者輸血，但這有免疫反應、感染疾病和血型相容性有限等風險。自體血輸血或細胞回收是收集患者在手術中流失的自身血液，過濾以清除雜質，然後重新註入患者體內。這個過程減少了對捐贈者血液的依賴，並將輸血反應和血液傳染感染疾病傳播的風險降至最低。自體輸血系統在涉及大量失血的手術（如心臟、整形外科和血管手術）以及創傷護理中特別有用。隨著技術的進步，自體輸血系統變得更加有效和緊湊，使其可用於更廣泛的臨床環境中，包括急診室和戰地醫療。透過利用患者自身的血液，這些系統提供了一種比傳統輸血更安全、更有效率、更具成本效益的替代方法，改善了患者的治療效果，並為血液保護樹立了新的標準。

自動輸血系統在各個醫療領域是如何應用的？

自體輸血系統功能多樣，已廣泛應用於各醫學專科，各專科均利用該技術滿足其獨特的外科和重症監護需求。在失血量較高的心血管外科手術中，自體輸血系統能夠維持穩定的血液容積和血紅素水平，從而減少對異體（捐贈者）輸血的需求。這在諸如開胸手術和動脈瘤修復等複雜手術中尤其重要，因為即使少量的血液供應減少也可能造成嚴重後果。整形外科手術也是自體輸血系統發揮重要作用的領域，尤其是在關節重建和脊椎手術中，這些手術可能會造成大量失血。自體輸血可以最大限度地降低輸血反應的風險，並透過避免使用異體血液製品來加速復原。在創傷和急診護理中，快速反應至關重要，自體輸血系統可以幫助臨床醫生在無法立即獲得捐贈者血液的情況下穩定患者病情。在產科，自體輸血系統可用於產後出血，降低大出血期間母嬰的風險。自動輸血系統的適應性使其在各種臨床環境中具有價值，可提高病患安全性，改善治療效果，並使醫療專業人員在手術和緊急情況下更好地控制血液管理。

在廣泛採用自動輸血系統的過程中，您面臨哪些挑戰？

儘管自體輸血系統具有諸多優勢，但在廣泛應用之前仍需克服許多挑戰。其中一個主要考慮因素是成本。自體輸血設備的購買和維護成本高昂，這使得資源有限的小型診所和醫院難以取得。此外，這些系統需要訓練有素的人員操作，並非所有醫療機構都擁有具備必要專業知識的人員，尤其是在農村和資源匱乏的地區。自體輸血並非適用於所有類型的手術或患有某些疾病（例如感染疾病或惡性腫瘤）的患者，而且回收血液的再輸血存在危險性。技術挑戰還在於需要對血液進行精確過濾和處理以確保再輸血的安全性，因為血液中殘留的污染物可能會引起副作用。此外，自體輸血的使用仍存在文化和患者自身的顧慮，某些患者不願接受從體內抽取的自身血液，或表達個人信仰，這些都進一步阻礙了自體輸血的接受。克服這些經濟、臨床和後勤挑戰需要有針對性的培訓計劃、提高成本效益和易用性的技術進步，以及努力教育醫療專業人員和患者了解自體輸血的安全性和有效性。

推動自體輸血系統市場成長的關鍵因素有哪些？

自動輸血系統市場在醫療技術進步、血液保護意識增強以及高失血量複雜手術日益普及的推動下實現了顯著成長。技術創新推動了更緊湊、更有效率、更易於使用的自動輸血系統的開發，這些系統可以應用於從大型醫院到小型診所的各種手術環境。這種多功能性擴展了自體輸血在多個外科學科的應用可能性，包括心血管外科、整形外科和創傷外科。此外，對病人安全和減少輸血相關併發症的日益關注，促使醫療保健提供者採取措施節約血液，減少對捐血的依賴。在全球血液供不應求和輸血性行為感染疾病日益嚴重的背景下，自體輸血提供了一種可靠的替代方案，可以減少對捐血的需求，這與醫院提高安全性和準備度的目標一致。人口老化，尤其是在已開發國家，也使自體輸血成為首選方案，因為接受手術的老年患者可能患有會增加異體輸血風險的疾病。此外，法規和醫療保健指南越來越重視包括自體輸血在內的血液管理策略，特別是在強調以患者為中心和具有成本效益的醫療保健的國家。技術進步、對更安全輸血的需求不斷成長、人口結構變化和支持性監管機構等多種因素共同推動自體輸血市場的成長，並使其成為現代醫療保健中有價值的解決方案。

部分

產品類型（自體輸血產品、自體輸血配件）、應用（心血管外科、整形外科、婦產科、神經外科、其他應用）

受訪公司範例

  • Atrium Medical Corporation（A Part of Getinge Group）
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Fresenius Medical Care AG & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • Livanova PLC
  • Medtronic PLC
  • Redax

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 比賽

簡介目錄
Product Code: MCP21289

Global Autotransfusion Systems Market to Reach US$467.7 Million by 2030

The global market for Autotransfusion Systems estimated at US$366.5 Million in the year 2024, is expected to reach US$467.7 Million by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Autotransfusion Products, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$336.2 Million by the end of the analysis period. Growth in the Autotransfusion Accessories segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$100.2 Million While China is Forecast to Grow at 4.0% CAGR

The Autotransfusion Systems market in the U.S. is estimated at US$100.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$74.7 Million by the year 2030 trailing a CAGR of 4.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.9% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Autotransfusion Systems Market - Key Trends and Drivers Summarized

What Are Autotransfusion Systems, and How Are They Transforming Blood Management in Surgery?

Autotransfusion systems are medical devices designed to collect, filter, and return a patient’s own blood during surgery, transforming how blood is managed in operating rooms and trauma settings. Traditionally, patients requiring blood during surgery have relied on donor blood transfusions, which can introduce risks such as immune reactions, infections, and limited availability of compatible blood types. Autotransfusion, or cell salvage, allows for the collection of a patient’s own blood that is lost during surgery, filtering and cleaning it of impurities before reinfusing it back into the patient. This process reduces dependence on donor blood and minimizes the risk of transfusion reactions and transmission of bloodborne diseases. Autotransfusion systems are particularly valuable in surgeries involving significant blood loss, such as cardiac, orthopedic, and vascular procedures, as well as in trauma care. As technology advances, autotransfusion systems have become more effective and compact, making them accessible in a wider range of clinical settings, including emergency rooms and battlefield medicine. By utilizing the patient’s own blood, these systems provide a safer, more efficient, and cost-effective alternative to traditional transfusions, enhancing patient outcomes and setting new standards in blood conservation.

How Are Autotransfusion Systems Being Utilized Across Different Medical Specialties?

The versatility of autotransfusion systems has led to their adoption across various medical specialties, each leveraging this technology to meet unique surgical and emergency care needs. In cardiovascular surgery, where blood loss can be significant, autotransfusion systems help maintain stable blood volume and hemoglobin levels, reducing the need for allogeneic (donor) blood transfusions. This is especially important in complex procedures such as open-heart surgeries or aneurysm repairs, where even a small reduction in blood supply can have serious consequences. Orthopedic surgery is another area where autotransfusion systems play a vital role, particularly in joint replacements and spinal surgeries that may involve considerable blood loss. Autotransfusion minimizes the risk of transfusion reactions and supports faster recovery by avoiding foreign blood products. In trauma and emergency care, where rapid response is critical, autotransfusion systems allow clinicians to stabilize patients in situations where donor blood may not be immediately available. In obstetric care, autotransfusion systems can be used in cases of postpartum hemorrhage, reducing the risk to mother and child when blood loss is substantial. The adaptability of autotransfusion systems makes them invaluable in diverse clinical settings, where they enhance patient safety, improve outcomes, and offer healthcare providers greater control over blood management in surgeries and emergencies.

What Challenges Do Autotransfusion Systems Face in Widespread Adoption?

While autotransfusion systems offer numerous benefits, several challenges must be overcome to achieve broader adoption. One major consideration is cost, as autotransfusion equipment can be expensive to acquire and maintain, making it less accessible for smaller clinics and hospitals with limited resources. Additionally, the operation of these systems requires trained personnel, and not all healthcare settings have staff with the necessary expertise, particularly in rural or under-resourced areas. Clinical limitations are another factor; autotransfusion is not suitable for all types of surgeries or for patients with certain conditions, such as infections or malignancies, where reinfusing salvaged blood may pose a risk. Technical challenges also arise from the need for precision in filtering and processing blood to ensure it is safe for reinfusion, as any contaminants left in the blood could cause adverse reactions. Furthermore, some cultural and patient-specific concerns surround the use of autotransfusion, with certain patients expressing reluctance or personal beliefs against receiving their own blood if it has left the body, presenting an additional barrier to its acceptance. Overcoming these economic, clinical, and logistical challenges requires targeted training programs, technological advancements to improve cost efficiency and usability, and efforts to educate both medical professionals and patients on the safety and efficacy of autotransfusion.

What Major Factors Are Behind the Growth of the Autotransfusion System Market?

The autotransfusion system market is experiencing notable growth, driven by advancements in medical technology, rising awareness of blood conservation, and the increasing prevalence of complex surgeries with high blood loss. Technological innovations have led to the development of more compact, efficient, and user-friendly autotransfusion systems that can be integrated into a wider variety of surgical environments, from large hospitals to smaller clinics. This versatility has expanded the potential for autotransfusion across multiple surgical fields, including cardiovascular, orthopedic, and trauma surgery. Furthermore, the growing focus on patient safety and reducing transfusion-related complications has spurred healthcare providers to adopt methods that conserve blood and lower dependence on donor supplies. With shortages in the global blood supply and concerns about transfusion-transmissible infections, autotransfusion offers a reliable alternative that reduces demand for donor blood, aligning with hospitals’ goals to improve safety and preparedness. The increase in aging populations, especially in developed countries, is also a factor, as older patients undergoing surgery may have conditions that make allogeneic transfusions riskier, making autotransfusion a preferred choice. Additionally, regulatory and healthcare guidelines now emphasize blood management strategies that include autotransfusion, particularly in countries focused on patient-centered and cost-effective care. These intersecting factors-technological advances, rising demand for safer transfusions, demographic changes, and regulatory support-are propelling the growth of the autotransfusion market, cementing it as a valuable solution in modern healthcare.

SCOPE OF STUDY:

The report analyzes the Autotransfusion Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Autotransfusion Products, Autotransfusion Accessories); Application (Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Atrium Medical Corporation (A Part of Getinge Group)
  • Becton, Dickinson and Company
  • Beijing ZKSK Technology Co., Ltd.
  • Braile Biomedica
  • Fresenius Medical Care AG & Co. KGaA
  • Gen World Medical Devices
  • Haemonetics Corporation
  • Livanova PLC
  • Medtronic PLC
  • Redax

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Autotransfusion Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Conservation Drives Growth in Autotransfusion Systems Market
    • Increasing Use of Autotransfusion in Cardiac and Orthopedic Surgeries Expands Market Applications
    • Here's How Advances in Autotransfusion Technology Improve Blood Recovery Efficiency
    • Growing Focus on Patient Safety Supports Adoption of Autotransfusion to Reduce Transfusion-Related Risks
    • Rising Incidence of Complex Surgeries Fuels Demand for Reliable Autotransfusion Systems
    • Increasing Emphasis on Minimally Invasive Procedures Drives Need for Compact Autotransfusion Devices
    • Here's How Autotransfusion Systems Enhance Blood Management in Trauma and Emergency Care
    • Advancements in Filtration Technology Improve Quality and Safety of Recycled Blood
    • Growing Adoption of Autotransfusion Systems in Military and Disaster Medicine Expands Market Scope
    • Here's How Increased Awareness of Blood-Borne Diseases Fuels Demand for Closed Autotransfusion Systems
    • Rising Demand for Blood Management Solutions in Developing Countries Supports Market Growth
    • Focus on Reducing Blood Supply Shortages Drives Adoption of Autotransfusion in Major Hospitals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Autotransfusion Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World 6-Year Perspective for Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 3: World Recent Past, Current & Future Analysis for Autotransfusion Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 4: World 6-Year Perspective for Autotransfusion Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Autotransfusion Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World 6-Year Perspective for Autotransfusion Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Orthopedic Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World 6-Year Perspective for Orthopedic Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 9: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 10: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 11: World Autotransfusion Systems Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiovascular Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiovascular Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Obstetrics & Gynecological Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Obstetrics & Gynecological Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurological Surgeries by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Neurological Surgeries by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 18: USA Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 19: USA 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • CANADA
    • TABLE 22: Canada Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 23: Canada 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 25: Canada 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • JAPAN
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 26: Japan Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Japan 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Japan 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • CHINA
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 30: China Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: China 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 32: China Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • EUROPE
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 34: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 35: Europe 6-Year Perspective for Autotransfusion Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Europe 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • FRANCE
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 40: France Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: France 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 42: France Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: France 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • GERMANY
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Germany 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • ITALY
    • TABLE 48: Italy Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Italy 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Italy 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • UNITED KINGDOM
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 52: UK Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: UK 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 54: UK Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: UK 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 56: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Rest of Europe 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Autotransfusion Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 60: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Asia-Pacific 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 64: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Systems by Type - Autotransfusion Products and Autotransfusion Accessories - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of World 6-Year Perspective for Autotransfusion Systems by Type - Percentage Breakdown of Value Sales for Autotransfusion Products and Autotransfusion Accessories for the Years 2025 & 2030
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Autotransfusion Systems by Application - Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Rest of World 6-Year Perspective for Autotransfusion Systems by Application - Percentage Breakdown of Value Sales for Cardiovascular Surgeries, Orthopedic Surgeries, Obstetrics & Gynecological Surgeries, Neurological Surgeries and Other Applications for the Years 2025 & 2030

IV. COMPETITION